The typical price for a newly approved prescription drug has surpassed $250,000, a new study shows, reflecting rising costs for insurers, patients.

Coverage of a new PCSK9 trial makes bold claims about prevention and risk reduction. But how well do they hold up to scrutiny ...

Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and ...

WASHINGTON (AP) — The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering U.S. patients a more effective treatment against one of the ...

Watch out, metastatic ER+/HER2- breast cancer. There’s a new targeted agent in town. On Tuesday, the U.S. Food and Drug Administration approved the drug gedatolisib, a multi-targeted kinase inhibitor ...

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering U.S.

Could a new drug that makes fat cells self-destruct be the next big GLP-1? CBL-514 targets fat cells, and a new study shows that it was effective in slimming down participants’ waistlines. Early data ...

An update to this study of ICER has been published here, thanks to conversation with and insight from Mitchell Stein, policy and communications director at ICER, who clarified the differences between ...

The first-of-its-kind drug offers a reprieve for people who live with the debilitating sleep disorder. By Carolyn Y. Johnson Many people have a cartoonish idea of narcolepsy, perhaps picturing someone ...

Please provide your email address to receive an email when new articles are posted on . The new drug application included data from the phase 3 ADVANCES OUTCOMES trial. The Prescription Drug User Fee ...

Add Yahoo as a preferred source to see more of our stories on Google. This photo provided by Revolution Medicines on Wednesday, Aug. 26, 2026 shows packaging for the new pancreatic cancer drug, ...